Posted by Michael Wonder on 20 Nov 2017
Bureaucracy and duplication: the reality of the PPRS
20 November 2017 - In the fourth in her series of five articles looking at the objectives of the PPRS, Leela Barham focuses on whether the Pharmaceutical Price Regulation Scheme has delivered on the aim of reducing bureaucracy and duplication.
The Pharmaceutical Price Regulation Scheme (PPRS) is a voluntary agreement between the Association of the British Pharmaceutical Industry and the UK Government, represented by the Department of Health in London.
The fourth objective in the scheme is to reduce bureaucracy and duplication as well as any unforeseen burdens on either party over the years of the agreement, 2014 to 2018.
